Clinical Trials Browser

Phase 1/2 × Active not recruiting × Daunorubicin × Clear all

NCT04817241 2025-11-10

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Phase 1/2 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute